--- title: "Liraglutide in India" description: "Liraglutide in India: daily injection GLP-1, CDSCO status, cost vs weekly semaglutide, and when physicians choose this drug class member. India-specific educ..." canonical: "https://www.kesho.health/keywords/liraglutide-india" markdown_url: "https://www.kesho.health/md/keywords/liraglutide-india" language: "en-IN" primary_keyword: "liraglutide India" --- # Liraglutide in India — daily GLP-1 explained > **Short answer:** Liraglutide is a CDSCO-approved GLP-1 receptor agonist requiring once-daily subcutaneous injection—unlike weekly semaglutide or tirzepatide. Monthly costs often run ₹8,000–₹12,000 in Indian pharmacies. Some physicians prefer daily dosing for finer titration in selected patients. Same Schedule H rules, thyroid precautions, and MTC/MEN2 contraindications apply as other GLP-1 drug class members. **Canonical HTML:** https://www.kesho.health/keywords/liraglutide-india **Markdown:** https://www.kesho.health/md/keywords/liraglutide-india ## Daily injection option **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **Monthly budget worksheet** — Plan medicine, labs, consultations, and travel costs for 12–24 months of GLP-1 therapy in India. [Monthly budget worksheet](https://www.kesho.health/glp-1-budget-worksheet) ## What makes liraglutide different from weekly semaglutide? Liraglutide requires once-daily subcutaneous injection versus weekly semaglutide pens—shorter half-life enables finer dose adjustment in some clinical scenarios. Both remain GLP-1 receptor agonists under CDSCO labels with shared contraindications. Convenience trade-offs favour weekly forms for many patients; daily injection suits others when physicians prioritise titration granularity. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. ## What indications does CDSCO approve for liraglutide? CDSCO-approved labels specify diabetes and chronic weight-management contexts under physician supervision—identical regulatory seriousness as other Schedule H GLP-1 medicines. Verify package inserts for current manufacturer list as generics evolve. Off-label social-media uses ignore label boundaries and safety screening. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## How do monthly rupee costs compare in 2026? Liraglutide often runs ₹8,000–₹12,000 monthly—mid-range between generic weekly semaglutide and premium tirzepatide. Daily injection frequency does not automatically mean lower total cost. Budget pens, needles, disposal, and quarterly labs alongside medicine line items. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## What injection burden does daily dosing create? Seven injections weekly versus one semaglutide injection affects travel, shift work, and needle anxiety profiles. Indian endocrine nurses train rotation techniques similar to weekly pens but with higher frequency. Missing occasional doses differs from missing weekly pens—physicians advise timing rules individually. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## When might specialists choose liraglutide over semaglutide? Selected patients needing slower titration steps, prior weekly-form intolerance, or historical familiarity in clinician practice may receive liraglutide—decisions are individual, not universal algorithms. Cost and adherence often favour generic weekly semaglutide when equivalent exposure suffices. Kesho does not rank brands or molecules. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## Do side effects differ on daily liraglutide? Nausea and GI symptoms still peak during titration—sometimes spread across more weeks with daily escalation schedules. Injection-site rotation across abdomen, thigh, and arm remains essential. Summer dehydration precautions mirror other GLP-1 class members during Indian heatwaves. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## How should liraglutide pens be stored? Unopened pens refrigerate at 2–8°C; in-use storage follows label specifications often allowing room temperature up to 30°C for defined periods—identical discipline to weekly pens during power cuts and travel. Never freeze; discard heat-exposed pens per insert guidance. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## Can liraglutide combine with other diabetes medicines? Metformin and SGLT2 pairings occur under RSSDI pathways; sulfonylurea and insulin combinations need hypoglycaemia monitoring. Polypharmacy including ayurvedic supplements requires full disclosure at Indian geriatric and metabolic clinics. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. ## Where is broader GLP-1 drug-class context on Kesho? Our GLP-1 explained India guide situates liraglutide within the full receptor agonist class alongside semaglutide and tirzepatide. This landing captures liraglutide-specific search intent. Pair with cost and side-effect guides before pharmacy visits. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. ## Quick questions ### Is Liraglutide in India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on liraglutide in india? Liraglutide is a CDSCO-approved GLP-1 receptor agonist requiring once-daily subcutaneous injection—unlike weekly semaglutide or tirzepatide. Monthly costs often run ₹8,000–₹12,000 in Indian pharmacies. Some physicians prefer daily dosing for finer titration in selected patients. Same Schedule H rules, thyroid precautions, and MTC/MEN2 contraindications apply as other GLP-1 drug class members. ## Complete guide [glp-1-explained-india](https://www.kesho.health/blog/glp-1-explained-india) · [MD](https://www.kesho.health/md/blog/glp-1-explained-india) ## Related guides - [GLP-1 Cost in India (2026): What Patients Actually Pay](https://www.kesho.health/blog/glp-1-cost-india-2026) - [Semaglutide in India: A Complete Patient Guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) - [GLP-1 Side Effects and Safety: What Indian Patients Should Know](https://www.kesho.health/blog/glp-1-side-effects-safety) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*